All
AstraZeneca, University of Oxford Collaborate on COVID-19 Vaccine
April 30th 2020AstraZeneca and the University of Oxford have announced that they will collaborate on the global development and distribution of the university’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection.